Herbal Formula Science (대한한의학방제학회지)

The Korean Medicine Society for the Herbal Formula Study (대한한의학방제학회)
권호 표지

Effects of Coptidis Rhizoma on the Change of Interleukin-6 and $TNF-{\alpha}$ Level induced by LPS I.C.V. Injection in Mice

황연(黃連)이 Lipopolysaccharide 뇌실 주입으로 유발된 생쥐의 IL-6와 $TNF-{\alpha}$ 변화에 미치는 영향

  • Sim Eun-Yeong (Formulae Pharmacology Dept, Oriental Medical School, Kyungwon University) ;
  • Yun Jeong-Moon (Formulae Pharmacology Dept, Oriental Medical School, Kyungwon University) ;
  • Lee Tae-Hee (Formulae Pharmacology Dept, Oriental Medical School, Kyungwon University)
  • 심은영 (경원대학교 한의과대학 방제학교실) ;
  • 윤정문 (경원대학교 한의과대학 방제학교실) ;
  • 이태희 (경원대학교 한의과대학 방제학교실)
  • Published : 2004.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study was conducted to investigate the effects of Coptidis Rhizoma on the plasma IL-6 and $TNF-{\alpha}$ level in mice by intracerebroventricular(I.C.V.) injection of Lipopolysaccharide (LPS). Method: 6 mice were assigned to each of the Normal group, the Control group, and the individual Experimental groups. In the Normal group only saline was administered intragastrically, and in the Control group LPS was injected intracerebroventricularly 1 hr after intragastric administration of saline. In the Experimental groups Coptidis Rhizoma(0.5g/kg, 1.0g/kg, 3.0g/kg) was administered intragastrically to mice 1 hr prior to LPS (100ng/mouse) I.C.V. Injection. To measure the plasma IL-6 and $TNF-{\alpha}$ level of mice, their blood samples were collected from retro-orbital venous plexus, immediately centrifuged at $4^{\circ}C$, and plasma was removed and stored frozen at $-83^{\circ}C$ for later determination of plasma IL-6 and $TNF-{\alpha}$. Result: 1. LPS I.C.V. Injection increased plasma IL-6 level significantly in a dose-dependent manner compared with Normal group. (P<0.01) The plasma IL-6 concentration reached a significant maximal level about 1 hr after LPS(100ng/mouse) I.C.V. Injection.(P<0.001) 2. Both the 0.5g/kg(Sample A) and 1.0g/kg(Sample B) groups to which Coptidis Rhizoma was administered intragastrically 1 hr prior to LPS(100ng/mouse) I.C.V. Injection showed insignificant lower plama IL-6 level in 1 hr than Control group(P>0.05), and 3.0g/kg group(Sample C) conversely showed higher plama IL-6 level than Control group. 3. LPS I.C.V. Injection increased plasma $TNF-{\alpha}$ level significantly in a dose-dependent manner compared with Normal group.(P<0.05) The plasma $TNF-{\alpha}$ concentration reached a significant maximal level about 1 hr after LPS(100ng/mouse) I.C.V. Injection.(P<0.001) 4. All Sample groups(0.5g/kg, 1.0g/kg, and 3.0g/kg) to which Coptidis Rhizoma was administered intragastrically with each constituent-dose 1 hr prior to LPS(100ng/mouse) I.C.V. Injection showed significant lower $TNF-{\alpha}$ plama level in 1 hr than Control group.(P<0.001) These data revealed that Coptidis Rhizoma might have anti inflammatory effect by reducing the plasma $TNF-{\alpha}$ level in a dose dependent manner in mice LPS I.C.V. Injection.

Keywords

References

  1. 본초학 전국 한의과대학 본초학교수 (공편저)
  2. 황련이 Lipopolysaccaride를 처리한 치주인대세포의 세포활성 및 IL-6생산에 미치는 영향 송기범
  3. 日藥理誌 v.53 berberine의 약리작용 지견 보유 內炭精一
  4. Chem. Pharm. Bull. v.18 Some observations on the cardiovascular Effects of 9-substituted berberine Fukuda, H.;Watanabe, K.;Kudo, Y.
  5. 日藥理誌 v.72 berberine 형 알칼로이드의 행동약리학적 연구(제1판), 황련 및 그의 함유성분의 중 추억제작용 山原條二
  6. Bacterial Endotoxin In vitro biological activities of endotoxin Morrison, D.C.;Cuncan, JR. J.L.;Goodman, S.A.
  7. 洗心湯에 의한 腦 星狀細胞로부터 炎症性 細胞活性物質의 分泌 抑制 效果 金兌憲
  8. 대한내과학회지 v.54 no.3 섬유모세포에서 내독소 자극에 따른 Interluekin-6 생성의 신호전달과정 주재학;기신영;문승혁;정성환;김현태;어수택;김응훈;박춘식
  9. J. Periodontol. v.59 Actinobacillus actionmycetemcomitans and Bacteroides gingivalis activate human peripheral monocytes to produce interleukin-1 and tumor necrosis factor Lindemann, R.A.;Economou, J.S.
  10. J. Dent. Res. v.67 Production of interleukin-1 and tumor necrosis factor by human peripheral monocytes: Activated by periodontal bacteria and extracted lipopolysaccharides Lindemann, R.A.;Economou, J.S.;Rothermel, H.
  11. J. Oral. Pathol. v.15 Advances in understanding cell interactions in tissue resorption : Relevance to the pathogenesis of periodontal diseases and a new hypothesis Meikle, M.C.;Heath, J.K.;Reynolds, J.J.
  12. 머크 매뉴얼 강병철
  13. FASEB J. v.2 Biology of interleukin-1 Dinarello, C.A.
  14. 黃連이 BEAS-2B 人間 氣管支 上皮細胞의 IL-6, IL-16, GM-CSF mRNA level에 미치는 影響 金東鎰;吳味子
  15. 陰戶病의 外用藥으로 응용되는 黃芩, 黃連, 및 大黃의 抗菌과 消炎效果 朴賢淑
  16. 黃連과 甘草 共沈物의 抗菌效果와 生體利用率에 관한 硏究 李南嬉
  17. 經藥分類典 李龍城
  18. Neuroendocrinology v.56 no.6 Increased circulating interleukin-1 and interleukin-6 after intracerebroventricular injection of lipopolysaccharide Gottschall, P.E.;Komaki, G.
  19. 東醫寶鑑 許浚
  20. Can. J. Microbiol. v.15 Berberine Sulface, antimicrobial activity, bioassay and mode of action Amin, A.H.;Abbasi, K.M.;Subbaiah, T.V.
  21. 漢藥臨床應用 李尙仁;安德均;辛民敎
  22. Inf & Immun. v.59 Endotoxin shedding by enter obacteria : free and cell-bound endotoxin differ in Limulus activity Mattsby-Baltzer, I.;Lindgren, K.;Lindholm, B.;Edebo, L.
  23. FASEB J. v.8 no.2 Bacterial endotoxin: molecular relationships of structure to activity and function Rietschel, E.T.;Kirikae, T.;Schade, F.U.;Mamat, U.;Schmidt, G.;Seydel, U.;Di Padova, F.(et al.)
  24. Ann. Rev. Med. v.38 Endotoxin and disease mechanisms Morrison, D.C.;Ryan, J.L.
  25. J. Bacterial. v.97 Alteration of physical, chemical and biological properties of endotoxin by treatment with mild alkali Niwa, M.;Milner, K.C.;Ribi, E.;Rudbach, J.A.
  26. J. Endod. v.8 no.1 Investigation of the role of endotoxin in periapical inflammation Pitts, D.L.;Williams, B.L.;Morton, T.H. Jr.
  27. Immunobiology Janeway;Charles, A.(ed.)
  28. Laboratory Investigation v.56 Tumor necrosis factor and interleukin 1. Cytokines with multipul overlapping biological activities Le, J.;VilceK, J.
  29. Lymphokine Cytokine Res. v.10 Interleukin 1$\beta$ stimulates bone resorption and inhibits bone formation in vivo Nguyen, L.;Dewhirst, F.E.;Hauschka, P.A.;Stashenko, P.
  30. Pharmacol. Ther. v.69 no.2 Cytokine and Their Receptors in the Central Nervous System: Physiology, Pharmacology and Pathology Rothwell, Nancy J.;Luheshi, Giamal;Toulmond, Sylvie
  31. Can. J. Physiol. Pharmacol. v.69 no.10 Interleukin-6 is a centrally acting endogenous pyrogen in the rat Rothwell, N.J.;Busbridge, N.J.;Lefeuvre, R.A.;Hardwick, A.J.;Gauldie, J.;Hopkins, S.J.
  32. Neuroimmunol. v.30 no.2-3 Induction and regulation of interleukin-6 gene expression in rat astrocytes Benveniste, E.N.;Sparacio, S.M.;Norris, J.G.;Grenett, H.E.;Fuller, G.M.
  33. J. Immunol. v.142 no.1 Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells Jirik, F.R.;Podor, T.J.;Hirano, T.;Kishimoto, T.;Loskutoff, D.J.;Carson, D.A.;Lotz, M.
  34. Inflamm. Res. v.48 no.2 Dose-dependence of bacterial lipolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans Vedder, H.;Schreiber, W.;Yassouridis, A.;Gudewill, S.;Galanos, C.;Pollmacher, T.
  35. Neuroimmunomodulation v.2 Role of the cytokines in the hypothalamic-pituitary-adrenal and gonadal axes Spangelo, B.L.;Judd, A.M.;Call, G.B.;Zumwalt, J.;Gorospe, W.C.
  36. Lancet. v.2 no.8678-8679 Oxpentifylline in endotoxaemia Zabel, P.;Wolter, D.T.;Schonharting, M.M.;Schade, U.F.